9 results
10-K
2013 FY
RVNC
Revance Therapeutics Inc
28 Mar 14
Annual report
12:00am
corporate governance, board oversight and transactional experience. Our board of directors believes that such experience allows Mr. Eastman to make
424B4
hoxhy4gx8t9
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
fb3t3r2
31 Dec 13
IPO registration
12:00am
DRS
qn12qbf5ysf
19 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next